Individual genomes on the horizon.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed.

1. Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.Mayo Clinic proceedings · 2011
   Trial
2. Trio exome sequencing identifies de novo variants in novel candidate genes in 19.62% of CAKUT families.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
   Article
3. The genetics and pathogenesis of CAKUT.Nature reviews. Nephrology · 2023
   Review
4. Reverse phenotyping facilitates disease allele calling in exome sequencing of patients with CAKUT.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
   Article
5. Novel homozygous variant inClinical case reports · 2020
   Article
6. Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019
   Article
7. Novel loss-of-function mutation inOncology letters · 2019
   Article
8. Genetic testing in steroid-resistant nephrotic syndrome: when and how?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2016
   Review
9. Clinical genomics: from a truly personal genome viewpoint.Human genetics · 2016
   Review
10. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity.Kidney international · 2016
    Article
11. VCGDB: a dynamic genome database of the Chinese population.BMC genomics · 2014
    Article
12. Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus.Journal of pediatric gastroenterology and nutrition · 2013
    Article
13. The regulatory landscape for actively personalized cancer immunotherapies.Nature biotechnology · 2013
    Article
14. Genetics patients' perspectives on clinical genomic testing.Personalized medicine · 2013
    Article
15. Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy.Genome medicine · 2013
    Article
16. Opportunities for cost reduction of medical care: part 3.Journal of community health · 2012
    Review
17. Exome sequencing can improve diagnosis and alter patient management.Science translational medicine · 2012
    Article
18. Genetic testing legislation in Western Europe-a fluctuating regulatory target.Journal of community genetics · 2012
    Article
19. New frontiers in animal research of psychiatric illness.Methods in molecular biology (Clifton, N.J.) · 2012
    Review
20. Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics.Genome medicine · 2012
    Review

Corrections and comments

• Commented on by
  Individual genomes on the horizon.2010
• Comment on
  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as